Kim R. Tsuchimoto
Chief Financial Officer at Monopar Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Monopar Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Monopar Therapeutics Inc. June 22, 202687.2%
-
Monopar Therapeutics Inc. June 17, 202578.9%
-
Monopar Therapeutics Inc. August 9, 202497.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 26, 2026 | Monopar Therapeutics Inc. | Open-market sale | −485 | $108.83 | $52,783 |
| Aug 26, 2026 | Monopar Therapeutics Inc. | Open-market sale | −615 | $109.56 | $67,379 |
| Aug 26, 2026 | Monopar Therapeutics Inc. | Open-market sale | −700 | $110.65 | $77,455 |
| Aug 26, 2026 | Monopar Therapeutics Inc. | Open-market sale | −1,098 | $111.84 | $122,800 |
| Aug 26, 2026 | Monopar Therapeutics Inc. | Open-market sale | −602 | $112.93 | $67,984 |
| Aug 26, 2026 | Monopar Therapeutics Inc. | Open-market sale | −590 | $113.84 | $67,166 |
| Jul 14, 2025 | Monopar Therapeutics Inc. | In-the-money exercise | +8,904 | $0.01 | $89 |
| Jul 14, 2025 | Monopar Therapeutics Inc. | Open-market sale | −8,904 | $40.00 | $356,160 |
| Jun 30, 2024 | Monopar Therapeutics Inc. | Option exercise | +9,957 | — | — |
| Jun 30, 2024 | Monopar Therapeutics Inc. | Shares withheld for tax | −2,998 | $0.73 | $2,189 |
| Mar 31, 2024 | Monopar Therapeutics Inc. | Option exercise | +9,956 | — | — |
| Mar 31, 2024 | Monopar Therapeutics Inc. | Shares withheld for tax | −4,082 | $0.68 | $2,776 |
| Jan 1, 2024 | Monopar Therapeutics Inc. | Option exercise | +1,231 | — | — |
| Jan 1, 2024 | Monopar Therapeutics Inc. | Shares withheld for tax | −505 | $0.34 | $172 |
| Dec 31, 2023 | Monopar Therapeutics Inc. | Option exercise | +9,957 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.